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2
Information on problem drug use is collected by the National Drug Treatment Reporting
System (NDTRS). The NDTRS is an epidemiological database on treated drug misuse. It was
established in 1990 in the Greater Dublin Area only and in 1995 it was extended to cover
other areas of the country. The objectives of the NDTRS are to provide reliable information on
the number and characteristics of people who are treated for problem drug use; and to
examine trends and patterns of problem drug use. It provides information relevant to the
health consequences and social implications of drug misuse and contributes to an
understanding of the epidemiology of drug misuse in Ireland. This series of papers presents
data by regional health board areas.
NDTRS methodology
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Drug treatment data are viewed as an indirect indicator of drug misuse and are used at national
and European levels to provide information on the characteristics of clients entering treatment,
and on patterns of drug misuse such as types of drugs used and consumption behaviours. They
are ‘valuable from a public health perspective to assess needs, … and to plan and evaluate
services’ (EMCDDA, 1998: 23). Information from the NDTRS is made available to service
providers and policy makers and forms an important element in informing local and national
drug policies. Based on NDTRS data a number of local areas were targeted for special attention
in 1996 (Ministerial Task Force, 1996). Initially eleven areas, ten in Dublin and one in Cork, all of
which were characterised by social and economic disadvantage, were designated as Local Drug
Task Force Areas (Ministerial Task Force, 1996). There are now fourteen areas: twelve in Dublin;
Data on treated drug misuse are routinely collected by staff at drug treatment agencies
throughout Ireland. Compliance with the NDTRS requires that a form be completed for each
person who receives treatment for problematic drug use. At national level, anonymous,
aggregated data are compiled by the Drug Misuse Research Division (DMRD), Health Research
Board (HRB). 
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to
ameliorate the psychological, medical or social state of individuals who seek help for their 
drug problems’. Treatment may therefore include non-medical (addiction counselling, group
therapy, psychotherapy), as well as medical interventions (detoxification, methadone
substitution programmes).  
The main elements of the reporting system are: 
a) All Treatment Contacts – the reporting of all clients receiving treatment during a given year,
and 
b) First Treatment Contacts – the reporting of the sub-group of clients who have never previously
been treated for problem drug use.
In the case of the ‘all contact’ data there is a possibility of duplication in the database, for
example, where a person receives treatment at more than one centre. This is estimated to be
small since the introduction of the Misuse of Drugs Regulations in 1998, whereby precautions are
taken to ensure that treatment by way of medical prescription is available from one source only.  
Treatment as an indicator of drug misuse
one in Cork; and one in Bray (Department of Tourism, Sport & Recreation, 2001). Local Drug Task Forces
were established with the aim of providing strategic local responses in areas where drug misuse was a
serious problem.
In the Government’s Building on Experience. National Drugs Strategy 2001-2008, the role of the NDTRS is
recognised in ensuring that the overall aims of the strategy are met. NDTRS data collection is one of the
actions identified and agreed by Government for implementation by Health Boards. It is stated that ‘all
treatment providers should co-operate in returning information on problem drug use to the DMRD of the
HRB’ (Department of Tourism, Sport & Recreation, 2001: 118).
The most serious drug problems in Ireland, associated with the use of heroin, occur mainly in Dublin
(National Co-ordinating Committee on Drug Abuse, 1991; O’Hare & O’Brien, 1992; Ministerial Task
Force, 1996; Moran et al., 1997; Farrell et al., 2000; O’Brien et al., 2000; Department of Tourism, Sport
& Recreation, 2001). In recognition of the fact that there is no single treatment modality for drug misuse
given the complex nature of problems associated with drug misuse, drug strategies in the EHB embrace
a harm reduction approach. Consequently a broad range of services covering prevention, treatment and
rehabilitation is provided to ensure higher levels of treatment access. These include addiction counselling
services, syringe exchange programmes3, drug substitution programmes (opiate detoxification,
methadone reduction, methadone maintenance) and rehabilitation programmes. Since 1996, drug
services in the EHB have undergone major expansion and have been described as ‘one of the more
innovative community drug service programmes in Europe’ (Farrell et al., 2000: 32).      
Data returns to the NDTRS4 for clients attending treatment services in the EHB during 1999, were
provided by 56 agencies: 50 non-residential, 5 residential and 1 prison. Out of a total number of 5380,
82 percent of clients were treated at non-residential centres, mainly specialised treatment centres and
satellite clinics; 8 percent were treated by general practitioners; and residential therapeutic communities
accounted for 8 percent of clients. A very small proportion (0.1 percent) were in a prison setting. Most
clients were participating in drug substitution/maintenance programmes.
Treatment provision
Between 1996 and 1999 the number of drug users presenting for treatment increased from 4283 in 1996
to 5380 in 1999 (Table 1a). This was due in part to an increase in service provision, and partly to an
increase in drug use. Almost all of those who received treatment in the EHB during 1999 were residents of
the area (5304/5380). A relatively small number of people were from outside the EHB catchment area - for
example, in 1999, 76 non-residents were treated in the EHB. Altogether in 1999, 5390 EHB residents were
treated for their drug use; a small proportion (less than 2 percent) were treated outside of the area
(N=86), mainly at residential treatment services in the Mid Western Health Board area (Table 1a).
Extent of the problem
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drug use
Table 1a. Number of All Treatment Contacts* by treatment area and area of residence of clients,
1996-1999
Year Total treated in EHB EHB residents EHB residents Others treated in Total EHB residents
treated in EHB treated elsewhere EHB treated
1996 4283 4173 36 110 4209
1997 4243 4117 95 126 4212
1998 5155 5050 92 105 5142
1999 5380 5304 86 76 5390
* Number of cases, as distinct from individuals, who received treatment for their problem drug use
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1 Counties Dublin, Kildare and Wicklow. The Eastern Health Board (EHB) was dissolved and replaced by the Eastern Regional Health
Authority (ERHA) and three new area health boards (the Northern, East Coast and South Western), under the Health (Eastern Regional
Health Authority) Act, 1999. The ERHA took over formal responsibility for health and personal social services in Dublin, Kildare and
Wicklow from 1 March 2000. As this paper refers to data collected prior to this date, the catchment area now covered by the ERHA will
be referred to as the EHB area
2 This paper includes data for 1996 to 1999 only, as a complete dataset was not available for 2000
3 No NDTRS data returns for syringe exchange programmes
4 It should be noted that NDTRS figures for those being treated in general practice and prison settings are currently under-represented in data 
returns. Efforts are being made to improve coverage in these areas
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There is a decreasing trend in the proportion of those treated each year for the first time (first contacts) -
the number of first contacts fell from 1648 in 1996 to 1255 in 1999 (Table 1b). The explanation for this
is not altogether clear but one factor may be the impact of the introduction of the Misuse of Drugs
(Supervision of Prescription and Supply of Methadone) Regulations, 19985 on the structure of treatment
services. The regulations placed restrictions on the provision of methadone maintenance services in the
general practice setting. Some drug users, who up to then had been attending general practitioners now
presented to treatment centres, with the result that places for new clients were limited. This, combined
with problems in establishing local drug treatment services meant that there was little scope to provide
new treatment places.    
Table 1b. Number of First Treatment Contacts* by treatment area and area of residence of 
clients, 1996-1999
Year Total treated in EHB EHB residents EHB residents Others treated in Total EHB residents
treated in EHB treated elsewhere EHB treated
1996 1648 1571 24 77 1595
1997 1169 1108 27 61 1135
1998 1151 1107 39 44 1146
1999 1255 1220 38 35 1258
* Number of people who received treatment for the first time ever
The typical client coming for treatment is male, in his early twenties and living in the family home.
Over the four-year period 1996 to 1999 the modal age (the most frequently occurring age) for all
clients was 20 or 21 years of age (Table 2a). Fewer clients are living in the family home - the proportion
fell from 70 percent in 1996 to 62 percent in 1999. On closer examination of the data it emerges that
more people are living alone (increasing from three percent in 1996 to six percent in 1999). The
proportion who were homeless remained stable at around three percent. In educational terms, the
proportion of those who had left school before the official school-leaving age of 15 years remained
relatively high at 28 or 29 percent (Table 2a). At least one aspect of the social condition of clients in the
EHB area is improving - the employment level increased from nine percent in 1996 to 26 percent in
1999. This is as might be expected, given the general favourable economic conditions in the country,
although it is still very low in comparison to that of the general population. It is indicative of the social
disadvantage of drug users and presents a challenge to policy makers, particularly in the area of
employment, if social exclusion and marginalisation issues are to be addressed.
Socio-demographic information 
Table 2a. Socio-demographic characteristics of All Treatment Contacts treated in the EHB, 1996-1999
Characteristics 1996 1997 1998 1999
% Males : % Females 71:29 69:31 69:31 67:33
Mean age (years) 24 24 25 26
Modal age (years) 20 21 20 21
% Under 18 years of age 13 11 8 4
% Living with parents/family 70 67 67 62
% Early school leavers* 29 28 29 28
% Still at school 4 3 2 2
% Employed 9 13 18 26
* Left school before the age of 15 years
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Trends among new clients are similar to those of the overall group, albeit at different levels (Table 2b).
New clients are somewhat younger, with a higher proportion of adolescents (under 18 year olds). In the
period under review, the proportion of adolescents fell from 24 percent in 1996 to 10 percent in 1999;
and in 1999 they were less likely to be living in the family home - the proportion fell from 78 percent in
1996 to 68 percent in 1999. Employment levels among new clients, which are higher than those of the
overall group, also show an improving trend, from 12 percent in 1996 to 30 percent in 1999 (Table 2b).
5 Statutory Instrument No. 225 of 1998
Problem drug use
Table 3a. Main Drug of Misuse of All Treatment Contacts treated in the EHB, 1996-1999
Main Drug of 1996 1997 1998 1999
Misuse N (%) N (%) N (%) N (%)
Opiates 3774 (88) 3779 (89) 4688 (91) 5045 (94)
Cocaine 20 (0) 30 (1) 61 (1) 39 (1)
Ecstasy 125 (3) 92 (2) 50 (1) 59 (1)
Amphetamines 10 (0) 15 (0) 28 (1) 20 (0)
Benzodiazepines 42 (1) 37 (1) 58 (1) 27 (1)
Volatile Inhalants 14 (0) 14 (0) 17 (0) 8 (0)
Cannabis 275 (6) 245 (6) 225 (4) 169 (3)
Other substances 16 (0) 18 (0) 15 (0) 13 (0)
Total 4283* 4243** 5155+ 5380
Percentages based on valid Ns of 4276*; of 4230**; of 5142+
Table 2b. Socio-demographic characteristics of First Treatment Contacts treated in the EHB, 1996-1999
Characteristics 1996 1997 1998 1999
% Males : % Females 71:29 70:30 73:27 70:30
Mean age (years) 21 22 22 24
Modal age (years) 19 19 20 19
% Under 18 years of age 24 20 20 10
% Living with parents/family 78 75 73 68
% Early school leavers* 24 21 25 23
% Still at school 7 7 7 5
% Employed 12 18 22 30
* Left school before the age of 15 years
Table 3b. Main Drug of Misuse of First Treatment Contacts treated in the EHB, 1996-1999 
Main Drug of 1996 1997 1998 1999
Misuse N (%) N (%) N (%) N (%)
Opiates 1307 (79) 905 (78) 899 (78) 1056 (84)
Cocaine 14 (1) 15 (1) 26 (2) 18 (1)
Ecstasy 96 (6) 65 (6) 30 (3) 41 (3)
Amphetamines 6 (0) 10 (1) 16 (1) 15 (1)
Benzodiazepines 6 (0) 13 (1) 11 (1) 4 (0)
Volatile Inhalants 11 (1) 6 (1) 13 (1) 5 (0)
Cannabis 199 (12) 143 (12) 146 (13) 110 (9)
Other substances 7 (0) 9 (1) 7 (1) 6 (0)
Total 1648* 1169** 1151+ 1255
Percentages based on valid Ns of 1646*; of 1166**; of 1148+
Trends among the sub-group of new clients (first contacts) were similar to those of the overall group of
all contacts, albeit at a lower level for opiates and a higher level for cannabis and ecstasy use (Table 3b).    
A closer scrutiny reveals that heroin use is on the increase, from 88 percent (N=3324) in 1996 to 93
percent (N=4685) in 1999; and injection of heroin increased from 52 percent in 1996 to 71 percent in
1999 (Table 4a). The fact that heroin is more likely to be injected than smoked, and that there is an
increasing trend in injecting heroin use, has very serious implications for the health of this population of
drug users. The use of other opiates such as codeine, dihydrocodeine and methadone was stable
Trends show
an increase in
the misuse of
opiates
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Information on the patterns of drug use, such as the types of drugs used, how they are taken, and
whether they are taken in combination with other drugs, can be useful in assessing and planning drug
treatment services. In the EHB area opiates are predominantly the main drugs causing problems and for
which most people present for treatment. Trends over the period 1996 to 1999 show an increase in the
misuse of opiates (Table 3a), from 88 percent in 1996 to 94 percent in 1999. The number of all (opiate)
contacts increased from 3774 in 1996 to 5045 in 1999. In comparison, the proportion using other types
of drugs is relatively small, and is decreasing. For example, problematic cannabis use decreased from six
percent in 1996 to three percent in 1999; and ecstasy use from three percent in 1996 to one percent 
in 1999.  
Table 4a. Opiate as a Main Drug of Misuse for All Treatment Contacts treated in the EHB, 1996-1999
Main Drug of 1996 1997 1998 1999
Misuse N (%) N (%) N (%) N (%)
Heroin 3324 (88) 3328 (88) 4167 (89) 4685 (93)
of whom:
injected 1739 (52) 2164 (65) 2736 (66) 3322 (71)
smoked 1507 (45) 1109 (33) 1283 (31) 1288 (27)
other route 23 (1) 19 (1) 22 (1) 16 (0)
not known 55 (2) 36 (1) 126 (3) 59 (1)
Other Opiates 450 (12) 451 (12) 521 (11) 360 (7)
Total 3774 3779 4688 5045
The pattern of heroin use among new clients in Dublin during the early 1990s was characterised by the
emergence of chasing the dragon (Smyth et al., 2000). This coincided with a surge in the number of
people entering treatment for the first time. Concern was expressed that the greater acceptability of
heroin chasing among new users might attract increasing numbers to heroin use (Smyth et al., 2000).
While heroin use has remained very high among new clients, the numbers in 1999 (N=1017) were less
than in 1996 (N=1266) (Table 4b). In 1996 they were more likely to smoke (61 percent) rather than inject
the heroin, then the trend began to change and by 1999 injecting became the most common route of
administration (59 percent) for heroin users presenting to treatment services for the first time (Table 4b).
It would seem that heroin users, who initially are reluctant to inject the drug, are more likely to do so once
their heroin use has become habitual (Cassin et al., 1998; Dillon, 2001; Moran et al., 2001). 
Drug users presenting for treatment are likely to be involved in the use of more than one drug (Table
5a).  Trends in secondary drug use show a high level of polydrug use, although the proportion decreased
slightly from 75 percent in 1996 and 1997 to 68 percent in 1998 and 1999 (Table 5a). Opiates,
benzodiazepines and cannabis are the drugs most likely to be involved. In 1998 there was a shift towards
benzodiazepines which became the most common secondary drug in 1999 (Table 5a). 
Table 4b. Opiate as a Main Drug of Misuse for First Treatment Contacts treated in the EHB, 1996-1999
Main Drug / Route 1996 1997 1998 1999
of Administration N (%) N (%) N (%) N (%)
Heroin 1266 (97) 872 (96) 849 (94) 1017 (96)
of whom:
injected 461 (36) 421 (48) 415 (49) 598 (59)
smoked 775 (61) 438 (50) 422 (50) 409 (40)
other route 9 (1) 4 (0) 3 (0) 1 (0)
not known 21 (2) 9 (1) 9 (1) 9 (1)
Other Opiates 41 (3) 33 (4) 50 (6) 39 (4)
Total 1307 905 899 1056
Table 5a. Secondary Drug of Misuse of All Treatment Contacts treated in the EHB, 1996-1999 
Secondary Drug 1996 1997 1998 1999
of Misuse N (%) N (%) N (%) N (%)
No second drug 1020 (25) 1054 (25) 1641 (32) 1734 (32)
Opiates 1011 (25) 1047 (25) 1037 (20) 968 (18)
Cocaine 110 (3) 177 (4) 272 (5) 406 (8)
Ecstasy 278 (7) 198 (5) 183 (4) 195 (4)
Amphetamines 35 (1) 53 (1) 58 (1) 45 (1)
Benzodiazepines 742 (18) 924 (22) 1017 (20) 1067 (20)
Volatile Inhalants 8 (0) 9 (0) 4 (0) 8 (0)
Cannabis 672 (16) 507 (12) 760 (15) 793 (15)
Alcohol 105 (3) 83 (2) 92 (2) 87 (2)
Other substances 104 (3) 111 (3) 91 (2) 77 (1)
Total 4283* 4243** 5155 5380
Percentages based on valid Ns of 4085*; of 4163**
There is an
increasing trend
in injecting
heroin use
Drug users
who initially
smoke heroin
are more likely
to inject once
their heroin
use becomes
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Trends show
high levels of
polydrug use
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between 1996 and 1998, and then it decreased in 1999, perhaps indicating that heroin as the drug of
choice was more readily available.
Among new clients there are also high levels of polydrug use, although with a decreasing trend, from 71
percent in 1996 to 58 percent in 1999 (Table 5b). In the case of new clients the pattern is somewhat
different with cannabis as the drug most likely to be involved (in 18 percent of cases in 1999), followed
by benzodiazepines and opiates (Table 5b).     
Table 5b. Secondary Drug of Misuse of First Treatment Contacts treated in the EHB, 1996-1999 
Secondary Drug 1996 1997 1998 1999
of Misuse N (%) N (%) N (%) N (%)
No second drug 450 (29) 378 (33) 450 (39) 523 (42)
Opiates 256 (16) 161 (14) 123 (11) 136 (11)
Cocaine 43 (3) 45 (4) 51 (4) 71 (6)
Ecstasy 148 (9) 82 (7) 67 (6) 72 (6)
Amphetamines 26 (2) 36 (3) 30 (3) 27 (2)
Benzodiazepines 216 (14) 190 (17) 138 (12) 152 (12)
Volatile Inhalants 6 (0) 2 (0) 2 (0) 4 (0)
Cannabis 324 (21) 188 (16) 244 (21) 232 (18)
Alcohol 53 (3) 27 (2) 22 (2) 23 (2)
Other substances 37 (2) 42 (4) 24 (2) 15 (1)
Total 1648* 1169** 1151 1255
Percentages based on valid Ns of 1559*; of 1151**
Over the four-year period, 1996 to 1999, the mean age of initial drug use was very young at 15 or 16
years of age (Tables 6a, 6b). The mean age at which injecting commenced was about 20 years of age
(Tables 6a, 6b). Injecting practices are presenting as a major problem with an increasing high proportion
(2501/4283 in 1996 and 4142/5380 in 1999) of clients having ever injected (Table 6a). Over half of
those who have injected have also engaged in sharing injecting equipment and were currently sharing
when they presented for treatment. The prevalence of risk behaviours such as injecting drug use and
sharing injecting equipment, has very serious implications for the health of this population of drug users,
particularly in relation to the transmission of infectious diseases such as hepatitis C and HIV.
Levels of risk behaviours are not as high among those attending treatment for the first time, but as is the
case among the overall group there is an increasing trend in high risk injecting and sharing practices
(Table 6b). In 1996 just over a third (610/1648) had ever injected, and this had increased to over half in
1999 (742/1255). Up to 1999 less than half of these had shared injecting equipment at some time; in
1999 the proportion increased to 57 percent (423/742).       
Risk behaviour
Table 6a. Risk Behaviours of All Treatment Contacts treated in the EHB, 1996-1999
Risk Behaviours 1996 1997 1998 1999
Mean age of initial drug use (years) 15 16 15 15
Mean age 1st injected (years) 19 20 20 20
Ever Injected  N 2501 2895 3602 4142
of whom:
‘ever shared’  N 1499 1750 2141 2705
‘currently injecting’  N 1474 1647 1931 1795
‘currently sharing’  N 375 442 505 488
Table 6b. Risk Behaviours of First Treatment Contacts treated in the EHB, 1996-1999
Risk Behaviours 1996 1997 1998 1999
Mean age of initial drug use (years) 15 16 15 16
Mean age 1st injected (years) 20 20 20 20
Ever Injected  N 610 525 522 742
of whom:
‘ever shared’  N 262 238 235 423
‘currently injecting’  N 412 356 343 348
‘currently sharing’  N 115 108 90 108
Mean age of
initial drug use
was very young
at 15 or 16
years of age
The prevalence
of high risk
behaviours has
very serious
health
implications
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Figures 1a and 1b provide a comparison of the rates of treated drug misuse among residents in different
health board areas of Ireland for all and first treatment contacts respectively6. As the majority of people
treated for problem drug use are in the 15-39 year age group, the rates were based on this age group of
the population in each health board area. It is immediately obvious that in the EHB area the rate is much
higher than in other regions of the country. However, there is not great variation in regional trends. In all
cases the trend shows an increase in those presenting to drug treatment services (Figure 1a). 
There was an upward trend in first treatment contacts between 1996 and 2000 in all regions (Figure 1b).
Increased provision of services at individual health board level is of course a factor that must be taken
into consideration when considering such trends. Where there are accessible drug user oriented services
provided, people are more likely to approach them. However, it would appear that the upward trends
also indicate a real increase in drug misuse.    
Regional trends
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Figure 1a. Trends in All Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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Figure 1b. Trends in First Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
Year
6 1999 is the latest date for which complete ERHA (former EHB) data are available
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• Data from the NDTRS provide a profile of drug users presenting to the treatment services. This gives planners and service providers an
insight into the number and type of clients availing of treatment services.
• Data on clients receiving treatment for the first time can indicate, over time, changing patterns and trends in problematic drug use. It is
thus possible to distinguish new populations of drug users coming for treatment, from more long term chronic drug users.
• A particular benefit of this database is that it provides a foundation for carrying out other more detailed investigations. The value increases
over time if data are collected systematically for a number of years. Examples include studies of changes in behaviour patterns in different
subgroups, or comparisons with samples of untreated drug users. The DMRD welcomes collaborative research using the NDTRS database.
• The DMRD will provide to the agency, if required, an analysis of returns made to the NDTRS. This can be very useful to the agency for end
of year appraisal of clients, or for research purposes.
Value of NDTRS
